The following is an excerpt from a press release.
HMP Global, the leading omnichannel healthcare company, today announced the GI Cancers Alliance, Inc. as a partner for the 2024 World Congress on Gastrointestinal Cancer, the premier international forum for GI cancer professionals committed to understanding the very latest research, engaging in global exchange, and advancing clinical outcomes.
The 26th congress will be held 3-6 July at the Centre de Convencions Internacional de Barcelona, and will bring together an international community of oncology, pathology, and hepatology experts, clinicians, and surgeons, as well as clinical researchers to share pioneering research on new approaches and best practices in treating patients with cancers of the gastrointestinal tract.
GI cancers are the most common and deadliest type of cancers, accounting for more than 4.5 million global deaths per year. The GI Cancers Alliance was founded in 2015 to create a stronger, more unified voice for all those affected by GI cancers. As a leader in the gastrointestinal cancer community, the GI Cancers Alliance works to raise awareness, provide education, and advocate for the prevention, treatment, and cure of GI cancers through a collaboration among advocacy groups, industry, and institutional partners.
“The GI Cancers Alliance is pleased to partner with HMP Global in providing patient-centered education and research updates from the 26th annual World Congress on Gastrointestinal Cancer,” said Martha Raymond, MA, Executive Director, GI Cancers Alliance. “We are honored to collaborate with more than 100 global patient advocacy organizations representing all gastrointestinal cancer types, and we look forward to sharing the cutting-edge research from the July 2024 World GI Congress with our global partners, patients, and GI cancer communities.”
The 2024 World GI scientific program will feature didactic lectures, tandem talks, debates, keynote lectures, and selected abstract presentations, examining a range of gastrointestinal malignancies through a mix of dynamic education and exchange. Dan Lowrie, President, Oncology, Gastroenterology & Autoimmune, HMP Education (a subsidiary of HMP Global), said the innovative research presented at World GI and its focus on education for oncology healthcare providers can save lives.
“Through its collaborations, GI Cancers Alliance creates a powerful voice for those impacted by GI cancers,” Lowrie said. “This partnership furthers the goals of both the World GI Congress and GI Cancers Alliance as we work toward improving care and outcomes for patients throughout the world.”
More than 3,000 delegates from over 95 countries attended the 2023 World GI Congress. The educational program at World GI provides all stakeholders with opportunities to learn, debate, discuss, and network in a very active scientific field where recent progress has led to improvements in patient outcomes.